Search

Your search keyword '"Guigay, Joël"' showing total 288 results
Start Over Author "Guigay, Joël"
288 results on '"Guigay, Joël"'

1. Adapted EXTREME regimen in the first-line treatment of fit, older patients with recurrent or metastatic head and neck squamous cell carcinoma (ELAN-FIT): a multicentre, single-arm, phase 2 trial

Author

Guigay, Joël, Le Caer, Hervé, Ferrand, François-Régis, Geoffrois, Lionel, Saada-Bouzid, Esma, Fayette, Jérôme, Sire, Christian, Cupissol, Didier, Blot, Emmanuel, Guillet, Pierre, Pavillet, Julien, Bozec, Laurence, Capitain, Olivier, Rolland, Frédéric, Debourdeau, Philippe, Pointreau, Yoann, Falandry, Claire, Lopez, Stéphane, Coutte, Alexandre, Chatellier, Thierry, Dalloz, Pierre, Ortholan, Cécile, Michel, Cécile, Lacas, Benjamin, Cheurfa, Nadir, Schwob, Dominique, Bourhis, Jean, Mertens, Cécile, and Aupérin, Anne

Published
2024
Full Text
View/download PDF

2. Cetuximab versus methotrexate in first-line treatment of older, frail patients with inoperable recurrent or metastatic head and neck cancer (ELAN UNFIT): a randomised, open-label, phase 3 trial

Author

Guigay, Joël, Ortholan, Cécile, Vansteene, Damien, Cupissol, Didier, Even, Caroline, Kaminsky, Marie-Christine, Sire, Christian, Blot, Emmanuel, Debourdeau, Philippe, Bozec, Laurence, Saada-Bouzid, Esma, Fayette, Jérôme, Dalloz, Pierre, Pointreau, Yoann, Caer, Hervé Le, Falandry, Claire, Digue, Laurence, Braccini, Antoine, Lopez, Stéphane, Guillet, Pierre, Michel, Cécile, Cheurfa, Nadir, Schwob, Dominique, Bourhis, Jean, Mertens, Cécile, and Aupérin, Anne

Published
2024
Full Text
View/download PDF

3. Integrating artificial intelligence into lung cancer screening: a randomised controlled trial protocol

Author

Paul Hofman, Sylvie Leroy, Jonathan Benzaquen, Bernard Padovani, Charles Hugo Marquette, Fontas Eric, Eric Fontas, Stephanie Lopez, Nesrine Rouis, Jacques Boutros, Allegra Maryline, Amamou-Elhani Faten, ARFI Thierry, Baque Jean, Baque-Juston Marie, Barel Remy, Barrios Baretto Deisy, Baudin Guillaume, Beck Camille, Bellmann Laurent, Benchetrit Maxime, Benkirane Mohamed-Taib, Benyoussef Sid Ali, Benzaquen Jonathan, Berthet Jean Philippe, Bonnard Eric, Bordone Olivier, Boutros Jacques, Boyer Guy-René, Bulsei Julie, Caillon Cynthia, Castelnau Olivier, Chalmin Jérémy, Chebib Ralph, Cohen Charlotte, Cruzel Coralie, Degoutte Aurélien, Delin Margot, Diascorn Yann, Doux Nathalie, Durand Lorraine, Duval Yannick, El Hemweh Omar, Fayada Julien, Felderhoof Eric, Feliciello Stéphane:, Femenia Richard, Ferrari Victoria, Francisci Marc Paul, Ghalloussi Hannah, Gomez-Caro-Andres Abel, Gora Assia, Griffonnet Jennifer, Gubeno Marie Christine, Guigay Joël, Hamila Marame, Harrathi Mohamed-Ali, Henaut Quentin, Herin Edouard, Hofman Paul, Hofman Véronique, ILIE Marius, Korzeniewski Sylvia, Lalvee Salomé, Lassalle Sandra, Le Heron Charles, Leray Loïc, Leriche Julien, Lerousseau Lionel, Leroy Sylvie, Lespinet Fabre Virginie, Lestrez Roxane, Leyssalle Axelle, Long Mira Elodie, Lopez Stephanie, Mahler Valentin, Maniel Charlotte, Marcano Xavier, Marco Roucayrol Sabine, Marquette Charles-Hugo, Martin Nicolas, Mistri Aurélie, Nicolle Isabelle, Novellas Sébastien, Oddo Frédéric, Otto Josiane, Padovani Bernard, PERQUIS Marie Pierre, Philibert Lorène, Pop Daniel, Pottier Héloïse, Raguin Olivier, Rolland Fabien, Rouis Nesrine, Rousset Johanna, Ruitort Frédéric, Sanfiorenzo Céline, Selva Eric, Tanga Virginie, Tardy Magalie, Thomas Olivier, Varenio Sophie, Verdoire Paul, Vigny Isabelle, Washetine Kévin, Zurlinden Olivier, Tarhini Adam, and Perrotin Cédric

Subjects
Medicine
Abstract

Introduction Lung cancer (LC) is the most common cause of cancer-related deaths worldwide. Its early detection can be achieved with a CT scan. Two large randomised trials proved the efficacy of low-dose CT (LDCT)-based lung cancer screening (LCS) in high-risk populations. The decrease in specific mortality is 20%–25%.Nonetheless, implementing LCS on a large scale faces obstacles due to the low number of thoracic radiologists and CT scans available for the eligible population and the high frequency of false-positive screening results and the long period of indeterminacy of nodules that can reach up to 24 months, which is a source of prolonged anxiety and multiple costly examinations with possible side effects.Deep learning, an artificial intelligence solution has shown promising results in retrospective trials detecting lung nodules and characterising them. However, until now no prospective studies have demonstrated their importance in a real-life setting.Methods and analysis This open-label randomised controlled study focuses on LCS for patients aged 50–80 years, who smoked more than 20 pack-years, whether active or quit smoking less than 15 years ago. Its objective is to determine whether assisting a multidisciplinary team (MDT) with a 3D convolutional network-based analysis of screening chest CT scans accelerates the definitive classification of nodules into malignant or benign. 2722 patients will be included with the aim to demonstrate a 3-month reduction in the delay between lung nodule detection and its definitive classification into benign or malignant.Ethics and dissemination The sponsor of this study is the University Hospital of Nice. The study was approved for France by the ethical committee CPP (Comités de Protection des Personnes) Sud-Ouest et outre-mer III (No. 2022-A01543-40) and the Agence Nationale du Medicament et des produits de Santé (Ministry of Health) in December 2023. The findings of the trial will be disseminated through peer-reviewed journals and national and international conference presentations.Trial registration number NCT05704920.

Published
2024
Full Text
View/download PDF

4. Tumors: Oto-Rhino-Laryngology

Author

Guigay, Joël, Ortholan, C., Auperin, A., Le Caer, H., Michel, C., Mertens, C., Hofman, Paul, Section editor, Boulahssass, Rabia, Section editor, Gu, Danan, editor, and Dupre, Matthew E., editor

Published
2021
Full Text
View/download PDF

5. A phase II study of monalizumab in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: The I1 cohort of the EORTC-HNCG-1559 UPSTREAM trial

Author

Galot, Rachel, Le Tourneau, Christophe, Saada-Bouzid, Esma, Daste, Amaury, Even, Caroline, Debruyne, Philip, Henry, Stéphanie, Zanetta, Sylvie, Rutten, Anemie, Licitra, Lisa, Canon, Jean-Luc, Kaminsky, Marie-Christine, Specenier, Pol, Rottey, Sylvie, Guigay, Joël, Kong, Anthony, Tinhofer, Inge, Borcoman, Edith, Dirix, Lieve, Raveloarivahy, Tiana, Fortpied, Catherine, Vanlancker, Maureen, Morfouace, Marie, Govaerts, Anne-Sophie, and Machiels, Jean-Pascal

Published
2021
Full Text
View/download PDF

7. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

Author

BABA-HAMED, Nabil, BABIN, Emmanuel, BERA, Guillaume, BETRIAN-LAGARDE, Sarah, BLOT, Emmanuel, BOMPAS, Emmanuelle, BOREL, Christian, BOUCHEKOUA, Mohamed, BOZEC LE MOAL, Laurence, BRUYAS, Amandine, CALAIS, Gilles, CARPIUC, Ioana, CHAPET, Sophie, CHATELLIER, Thierry, CHAUFFERT, Bruno, CHELI, Sandrine, CLATOT, Florian, COJOCARASU, Oana, CORNELLY, Alexandre, COUTTE, Alexandre, DALLOZ, Pierre, DARLOY, Franck, DELHOMMEAU, Melissa, DE RAUCOURT, Dominique, DEBELLEIX, Christophe, DEBOURDEAU, Philippe, DILLIES-LEGRAIN, Anne Françoise, DO, Pascal, DUBOS-ARVIS, Catherine, DUCOULOMBIER, Agnès, EL KOURI, Claude, FALKOWSKI, Sabrina, FERRAND, François-Regis, GATINEAU, Michel, GERVAIS, Radj, GRAS, Louis, GUILLET, Pierre, HASBINI, Ali, HENAULT, Stéphane, HERRERA GOMEZ, Ruth Gabriela, HUGUET, Florence, KAMINSKY, Marie Christine, LAGRANGE, Aurélie, LAVAU-DENES, Sandrine, LE CAER, Hervé, LE FOLL, Christine, LEFEBVRE, Gautier, LINOT, Benjamin, LOPEZ, Qian, LORTHOLARY, Alain, MATIAS, Margarida, MAYACHE-BADIS, Lamia, MINNE, Floriane, MOLLON, Delphine, NEIDHARDT, Eve Marie, PAVILLET, Julien, PEYRADE, Frédéric, POINTREAU, Yohann, RAMEE, Jean-François, RAUCHE, Camille, RICHARD, Sandrine, RIZZO, Claudia, ROLLAND, Frédéric, SCHLURMANN, Friderike, STEFANI, Laetitia, TASSY, Louis, TAZI, Youssef, THERY, Jean-Christophe, TORTI EL ZEIN, Florida, TOULLEC, Clémence, TOURANI, Jean-Marc, TOUSSAINT, Philippe, VANBOCKSTAEL, Julie, VAULEON, Elodie, VIRET, Frédéric, WALER, Sabine, ATZPODIEN, Jens, BEHRENS, Caecilia, BUSCH, Chia Jung, DIETZ, Andreas, FELDMANN, Georg, FIETKAU, Rainer, GRANIZKA, Thordis, GREWE, Jürgen, GUNTINAS-LICHINUS, Orlando, HADLER-MIKESCH, Kristina, HAHN, Dennis, INHESTERN, Johanna, KELLNER, Karolin, KLINGHAMMER, Konrad, KRONENBERGER, Roland, LUEDTKE-HECKENKAMP, Kerstin, OCHSENREITHER, Sebastian, OTREMBA, Burkhard, PEUKER, Caroline Anna, PIRLICH, Markus, ROTHMANN, Frank, TOMETTEN, Mareike, WOHLFARTH, Sabine, ZEBRALLA, Veit, ZIPFEL, Matthias, ADANSA KLEIN, Juan Carlos, ARRAZUBI, Virginia, CABALLERO DAROQUI, Javier, CASTELO, Beatriz, CIRAUQUI CIRAUQUI, Beatriz, CRUZ HERNANDEZ, Juan Jesus, GALLEGO, Oscar, IGLESIAS DOCAMPO, Lara Carmen, LOPEZ POUSA, Antonio, MARTINEZ DEL PRADO, Maria, MARTINEZ-TRUFERO, Javier, PASTOR BORGONON, Miguel, PEREZ RUIZ, Elisabeth, QUIROGA GARCIA, Vanesa, RUBIO CASADEVALL, Jordi, VAZQUEZ FERNANDEZ, Silvia, Guigay, Joël, Aupérin, Anne, Fayette, Jérôme, Saada-Bouzid, Esma, Lafond, Cédrik, Taberna, Miren, Geoffrois, Lionnel, Martin, Laurent, Capitain, Olivier, Cupissol, Didier, Castanie, Hélène, Vansteene, Damien, Schafhausen, Philippe, Johnson, Alison, Even, Caroline, Sire, Christian, Duplomb, Sophie, Evrard, Camille, Delord, Jean-Pierre, Laguerre, Brigitte, Zanetta, Sylvie, Chevassus-Clément, Cécile, Fraslin, Aldéric, Louat, Fanny, Sinigaglia, Laura, Keilholz, Ulrich, Bourhis, Jean, and Mesia, Ricard

Published
2021
Full Text
View/download PDF

8. Avelumab–cetuximab–radiotherapy versus standards of care in locally advanced squamous-cell carcinoma of the head and neck: The safety phase of a randomised phase III trial GORTEC 2017-01 (REACH)

Author

Tao, Yungan, Aupérin, Anne, Sun, Xushan, Sire, Christian, Martin, Laurent, Coutte, Alexandre, Lafond, Cedrik, Miroir, Jessica, Liem, Xavier, Rolland, Frederic, Even, Caroline, Nguyen, France, Saada, Esma, Maillard, Aline, Colin-Batailhou, Natacha, Thariat, Juliette, Guigay, Joël, and Bourhis, Jean

Published
2020
Full Text
View/download PDF

11. Afatinib as second-line treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck: Subgroup analyses of treatment adherence, safety and mode of afatinib administration in the LUX-Head and Neck 1 trial

Author

Haddad, Robert, Guigay, Joel, Keilholz, Ulrich, Clement, Paul M., Fayette, Jérôme, de Souza Viana, Luciano, Rolland, Frédéric, Cupissol, Didier, Geoffrois, Lionnel, Kornek, Gabriela, Licitra, Lisa, Melichar, Bohuslav, Ribaldo Nicolau, Ulisses, Rauch, Daniel, Zanetta-Devauges, Sylvie, Cohen, Ezra E.W., Machiels, Jean-Pascal, Tahara, Makoto, Vermorken, Jan, Geng, Yuan, Zografos, Eleftherios, and Gauler, Thomas

Published
2019
Full Text
View/download PDF

13. Intérêts et limites de la recherche du déficit en dihydropyrimidine déshydrogénase dans le suivi des patients traités par fluoropyrimidines : résultats de deux enquêtes nationales de pratiques réalisées auprès des médecins et des biologistes

Author

Loriot, Marie-Anne, Masskouri, Fadil, Carni, Paolo, Le Malicot, Karine, Seitz, Jean-François, Michel, Pierre, Legoux, Jean-Louis, Bouché, Olivier, André, Thierry, Faroux, Roger, Delaloge, Suzette, Malka, David, Guigay, Joel, Thariat, Juliette, Thomas, Fabienne, Barin-Le-Guellec, Chantal, Ciccolini, Joseph, Boyer, Jean-Christophe, and Étienne-Grimaldi, Marie-Christine

Published
2019
Full Text
View/download PDF

17. Predicting early death in older adults with cancer

Author

Boulahssass, Rabia, Gonfrier, Sebastien, Ferrero, Jean-Marc, Sanchez, Marine, Mari, Véronique, Moranne, Olivier, Rambaud, Cyrielle, Auben, Francine, Hannoun levi, Jean-Michel, Bereder, Jean-Marc, Bereder, Isabelle, Baque, Patrick, Turpin, Jean Michel, Frin, Anne-Claire, Ouvrier, Delphine, Borchiellini, Delphine, Largillier, Remy, Sacco, Guillaume, Delotte, Jerome, Arlaud, Cyprien, Benchimol, Daniel, Durand, Matthieu, Evesque, Ludovic, Mahamat, Abakar, Poissonnet, Gilles, Mouroux, Jérôme, Barriere, Jérôme, Benizri, Emmanuel, Piche, Thierry, Guigay, Joel, Francois, Eric, and Guerin, Olivier

Published
2018
Full Text
View/download PDF

18. Nivolumab vs investigator’s choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression

Author

Ferris, Robert L., Blumenschein, George, Jr., Fayette, Jerome, Guigay, Joel, Colevas, A. Dimitrios, Licitra, Lisa, Harrington, Kevin J., Kasper, Stefan, Vokes, Everett E., Even, Caroline, Worden, Francis, Saba, Nabil F., Docampo, Lara Carmen Iglesias, Haddad, Robert, Rordorf, Tamara, Kiyota, Naomi, Tahara, Makoto, Lynch, Mark, Jayaprakash, Vijayvel, Li, Li, and Gillison, Maura L.

Published
2018
Full Text
View/download PDF

20. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

Author

Harrington, Kevin J, Ferris, Robert L, Blumenschein, George, Jr, Colevas, A Dimitrios, Fayette, Jérôme, Licitra, Lisa, Kasper, Stefan, Even, Caroline, Vokes, Everett E, Worden, Francis, Saba, Nabil F, Kiyota, Naomi, Haddad, Robert, Tahara, Makoto, Grünwald, Viktor, Shaw, James W, Monga, Manish, Lynch, Mark, Taylor, Fiona, DeRosa, Michael, Morrissey, Laura, Cocks, Kim, Gillison, Maura L, and Guigay, Joël

Published
2017
Full Text
View/download PDF

21. Poorly differentiated gastro-entero-pancreatic neuroendocrine carcinomas: Are they really heterogeneous? Insights from the FFCD-GTE national cohort

Author

Stephanie, Laetitia, Borbath, Ivan, Castex, Petorin, Caroline, Terrebonne, Eric, Bouhier-Leporrier, Karine, Suc, Etienne, Hautefeuille, Vincent, Bourgeois, Vincent, Cany, Laurent, Dewaele, François, Niccoli, Patricia, Seitz, Jean-François, Lecaille, Cédric, Rebischung, Christine, Rossi, Valérie, Baconnier, Mathieu, Dubreuil, Olivier, Ferec, Marc, Deplanque, Gael, Geslin, Guillaume, Wanicki Caron, Isabelle, Lavau Denes, Sandrine, Bedenne, Laurent, Ligeza, Catherine, Maringe, Eric, Ran-Royo, Anne-Laure, Guigay, Joel, Rougier, Philippe, Walter, T., Tougeron, D., Baudin, E., Le Malicot, K., Lecomte, T., Malka, D., Hentic, O., Manfredi, S., Bonnet, I., Guimbaud, R., Coriat, R., Lepère, C., Desauw, C., Thirot-Bidault, A., Dahan, L., Roquin, G., Aparicio, T., Legoux, J.-L., Lombard-Bohas, C., Scoazec, J.-Y., Lepage, C., and Cadiot, G.

Published
2017
Full Text
View/download PDF

25. Evaluation of the information given to patients undergoing head and neck cancer surgery using the EORTC QLQ-INFO25 questionnaire: A prospective multicentric study

Author

Bozec, Alexandre, Schultz, Philippe, Gal, Jocelyn, Chamorey, Emmanuel, Chateau, Yann, Dassonville, Olivier, Poissonnet, Gilles, Santini, José, Peyrade, Frédéric, Saada, Esma, Guigay, Joël, Benezery, Karen, Leysalle, Axel, Santini, Laure, Giovanni, Antoine, Messaoudi, Lila, and Fakhry, Nicolas

Published
2016
Full Text
View/download PDF

34. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

Author

Machiels, Jean-Pascal H, Haddad, Robert I, Fayette, Jérôme, Licitra, Lisa F, Tahara, Makoto, Vermorken, Jan B, Clement, Paul M, Gauler, Thomas, Cupissol, Didier, Grau, Juan José, Guigay, Joël, Caponigro, Francesco, de Castro, Gilberto, Jr, de Souza Viana, Luciano, Keilholz, Ulrich, del Campo, Joseph M, Cong, Xiuyu Julie, Ehrnrooth, Eva, and Cohen, Ezra E W

Published
2015
Full Text
View/download PDF

35. Supplementary Table 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

36. Supplementary Table 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

37. Supplementary Table 5 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

38. Supplementary Figure 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

39. Supplementary Figure 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

40. Supplementary Table 4 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

41. Supplementary Figure 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

42. Supplementary Table 7 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

43. Supplementary Table 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

44. Supplementary Table 6 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

46. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: oncologic and functional outcomes and prognostic factors

Author

Bozec, Alexandre, Benezery, Karen, Ettaiche, Marc, Chamorey, Emmanuel, Vandersteen, Clair, Dassonville, Olivier, Poissonnet, Gilles, Riss, Jean-Christophe, Hannoun-Lévi, Jean-Michel, Chand, Marie-Eve, Leysalle, Axel, Saada, Esma, Guigay, Joël, Sudaka, Anne, Demard, François, Santini, José, and Peyrade, Frédéric

Published
2016
Full Text
View/download PDF

48. Targeted therapy-induced radiation recall

Author

Levy, Antonin, Hollebecque, Antoine, Bourgier, Céline, Loriot, Yohann, Guigay, Joël, Robert, Caroline, Delaloge, Suzette, Bahleda, Rastislav, Massard, Christophe, Soria, Jean-Charles, and Deutsch, Eric

Published
2013
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results